NASDAQ · SHPH
Shuttle Pharmaceuticals Holdings, Inc.
$5.23-$0.01 (-0.19%)
Shuttle Pharmaceuticals Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.22% below the high.
Loading market information…
NASDAQ · UPC · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Universe Pharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.43% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:53 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$5.23-$0.01 (-0.19%)
Shuttle Pharmaceuticals Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.22% below the high.
$2.64+$0.07 (+2.72%)
PMGC Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.82% below the high.
$0.01$0.00 (0.0%)
NKGen Biotech, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.56% below the high.
$2.69-$0.01 (-0.3%)
NewcelX Ltd.’s quoted price sits in the lower half of its reported 52-week range, 67.57% below the high.
$1.37-$0.14 (-9.27%)
Moolec Science S.A.’s quoted price sits in the lower half of its reported 52-week range, 94.1% below the high.
$0.54-$0.03 (-5.08%)
Bluejay Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.1% below the high.
$0.15+$0.02 (+11.11%)
BriaCell Therapeutics Corp. Warrant’s quoted price sits in the lower half of its reported 52-week range, 65.91% below the high.
$0.26-$0.03 (-10.46%)
Tivic Health Systems, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.4% below the high.
